Doctors test 'Bubble Boy' gene cure with lower cancer risk
NCT ID NCT01410019
Summary
This trial tested a refined gene therapy to cure boys born with a severe, life-threatening immune deficiency called SCID-X1. For infants without a suitable bone marrow donor, doctors collected their own blood stem cells, inserted a corrected gene in the lab, and returned the cells. The main goal was to see if this safer version of the therapy could rebuild their immune systems without causing cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for X-LINKED SEVERE COMBINED IMMUNODEFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hopital Necker
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.